• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, May 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia

Bioengineer by Bioengineer
September 13, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Use of contralateral prophylactic mastectomy (CPM) for the treatment of breast cancer has increased markedly over the last decade in the wake of greater patient awareness of the procedure. Currently, about 20 percent of patients receive CPM, representing about half of those who get any mastectomy. Little is known about the influence of the attending surgeon on variations in receipt of CPM. Steven J. Katz, M.D., M.P.H., of the University of Michigan, Ann Arbor, and colleagues surveyed 7,810 women with stages 0 to II breast cancer and 488 attending surgeons identified by the patients to quantify the influence of the attending surgeon on rates of CPM and clinician attitudes that explained it. Surveys were sent approximately two months after surgery.

A total of 5,080 women responded to the survey (70 percent response rate), and 377 surgeons responded (77 percent response rate). The researchers found that the individual attending surgeon explained a large amount (20 percent) of the overall variation in CPM use: the estimated rate of CPM was 34 percent for surgeons who least favored initial breast conservation and were least reluctant to perform CPM vs 4 percent for surgeons who most favored initial breast conservation and were most reluctant to perform CPM. One-quarter (25 percent) of the surgeon influence was explained by attending attitudes about initial recommendations for surgery and responses to patient requests for CPM.

The study notes some limitations, including that despite high survey response rates, there was inevitable decay in the sample given the requirement for completed surveys from both the surgeon and the patient.

"Our findings reinforce the need to address better ways to communicate with patients with regard to their beliefs about the benefits of more extensive surgery and their reactions to the management plan including surgeon training and deployment of decision aids," the authors write.

###

For more details and to read the full study, please visit the For The Media website.

(doi:10.1001/jamasurg.2017.3415)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Contact

Nicole Fawcett
[email protected]
@JAMA_current

http://www.jamamedia.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Sanguinarine: The Key that Flips BiP to Battle Lung Cancer

May 26, 2026

Lund University Professor Appointed Chair of Lancet Commission on Precision Medicine

May 26, 2026

Platinum-Antibody Conjugates Enhance Tumor Recognition by the Immune System

May 26, 2026

Johns Hopkins Medicine Researchers Find Hydroxychloroquine May Shield Skin Lupus Patients from Heart and Metabolic Risks

May 26, 2026
Please login to join discussion

POPULAR NEWS

  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    317 shares
    Share 127 Tweet 79
  • New Study Reveals Plants Can Detect the Sound of Rain

    735 shares
    Share 293 Tweet 183
  • Common Food Preservatives Associated with Elevated Blood Pressure and Increased Heart Disease Risk

    56 shares
    Share 22 Tweet 14
  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    847 shares
    Share 339 Tweet 212

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sanguinarine: The Key that Flips BiP to Battle Lung Cancer

Lund University Professor Appointed Chair of Lancet Commission on Precision Medicine

Platinum-Antibody Conjugates Enhance Tumor Recognition by the Immune System

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.